Zhi Tong Cai Jing·2025-09-04 22:36Core Viewpoint - Fosun International (00656) announced the sale of a 40% stake in Luz Saúde, S.A. for €310 million, aiming to optimize capital structure and enhance liquidity while maintaining control over key strategic assets in the healthcare sector [1] Group 1: Transaction Details - The agreement was signed on September 4, 2025, between Fidelidade (the seller) and MEIF7 (the buyer) [1] - Post-transaction, the seller will hold 59.86% of the shares and voting rights in the target company, which will remain a subsidiary of Fosun International [1] Group 2: Strategic Benefits - The sale is based on three key benefits: 1. Optimizing the seller's capital structure and improving liquidity [1] 2. Collaborating with an experienced strategic partner to drive business development and value creation while retaining control over critical assets in the healthcare sector [1] 3. Strengthening the equity structure to provide stronger support and momentum for the target company's mid-term growth [1] Group 3: Company Background - Luz Saúde, S.A. is one of the largest private healthcare groups in the Portuguese market, offering a wide range of comprehensive hospital and clinical services [1] - As of the announcement date, Luz Saúde is a subsidiary of Fidelidade [1]